ID

30160

Descrizione

Study ID: 108414 Clinical Study ID: DBU108414 Study Title: TXA107979: A placebo-controlled, single blind, randomized two part study to investigate the tolerability, pharmacokinetics, and brainDopamine D3 receptor occupancy of increasing repeat doses ofGSK618334 for up to 21 days in healthy volunteers. Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT01036061 https://clinicaltrials.gov/ct2/show/NCT01036061 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: GSK618334 Study Indication: Substance Dependence Documentation part: Logs/Repeats- Scales/Questionnaires

collegamento

https://clinicaltrials.gov/ct2/show/NCT01036061

Keywords

versioni (1)

1. 16/05/18 16/05/18 -

Titolare del copyright

GlaxoSmithKline

Caricato su

16 maggio 2018

DOI

Per favore, per richiedere un accesso.

Licenza